Physician

David Dasher, M.D.

According to 2025 Medicare claims, David Dasher, M.D. (NPI: 1821210337) practices dermatology in the Burlington, NC market, with the plurality of this provider's patient population coming from Alamance, NC. This provider's primary affiliated billing organization is ALAMANCE DERMATOLOGY, P.A. (NPI: 1346537180; TIN: 452150951) and primary practice location at 27217-3100. Dasher is affiliated with the Triad HealthCare Network, LLC. (ACO ID: D0209), participating under the REACH model.

Dasher's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 589 traditional Medicare patients, billed 5,464 HCPCS/CPT codes, and received $206,249 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 1,054 prescription claims across 454 beneficiaries totaling $23,628 in drug costs, led by Clobetasol Propionate (Clobetasol Propionate). Open Payments data shows 16 records totaling $375. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have fallen sharply in recent years, from $238,783 to $23,628. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$157K$314K2015 Medicare payment: $313,739 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $257,154 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $288,662 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $278,121 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $292,018 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $259,377 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $271,666 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $260,231 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $272,448 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $206,249 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20157476,500$313,739
20167496,033$257,154
20178007,112$288,662
20188527,183$278,121
20198526,762$292,018
20207276,203$259,377
20217226,832$271,666
20227336,556$260,231
20237716,776$272,448
20245895,464$206,249

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$130K$259K2015 Drug cost: $238,783 (USD; Tot_Drug_Cst)2016 Drug cost: $217,687 (USD; Tot_Drug_Cst)2017 Drug cost: $199,074 (USD; Tot_Drug_Cst)2018 Drug cost: $259,356 (USD; Tot_Drug_Cst)2019 Drug cost: $217,839 (USD; Tot_Drug_Cst)2020 Drug cost: $151,394 (USD; Tot_Drug_Cst)2021 Drug cost: $179,278 (USD; Tot_Drug_Cst)2022 Drug cost: $58,873 (USD; Tot_Drug_Cst)2023 Drug cost: $58,225 (USD; Tot_Drug_Cst)2024 Drug cost: $23,628 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015383930$238,783
2016419985$217,687
2017424951$199,074
20184411,025$259,356
2019411922$217,839
2020378858$151,394
2021394937$179,278
2022397908$58,873
2023398895$58,225
20244541,054$23,628

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths104121$68
11102Biopsy of related skin growth, first growth244331$56
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more502663$54
17000Destruction of precancer skin growth, 1 growth443611$31
17003Destruction of precancer skin growth, 2-14 growths3962,645$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Clobetasol PropionateClobetasol Propionate1323,256$3,513
KetoconazoleKetoconazole2126,014$2,289
MetronidazoleMetronidazole20720$1,612
Hydroxychloroquine SulfateHydroxychloroquine Sulfate211,470$1,042
Mometasone FuroateMometasone Furoate671,822$959

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.16$375ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for David Dasher, M.D.?

Tedicare shows public-source Medicare data for David Dasher, M.D. (NPI 1821210337), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Dasher, M.D. have ACO affiliation data?

David Dasher, M.D. is shown with ACO affiliation data for Triad HealthCare Network, LLC. (REACH, ACO ID D0209).

What billing organization is linked to David Dasher, M.D.?

David Dasher, M.D. is linked to ALAMANCE DERMATOLOGY, P.A. (billing NPI 1346537180) in the available physician profile data.

Does David Dasher, M.D. have Open Payments data?

David Dasher, M.D. has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.